Literature DB >> 33662140

The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.

L Ji1, Y Chen2, L Xie2, Z Liu2,3.   

Abstract

Dedicator of cytokinesis 2 (Dock2), an atypical guanine exchange factor, is specifically expressed on immune cells and mediates cell adhesion and migration by activating Rac and regulates actin cytoskeleton remodeling. It plays a crucial role in the migration, formation of immune synapses, cell proliferation, activation of T and B lymphocytes and chemotaxis of pDCs and neutrophils. However, in-vivo physiological functions of Dock2 have been relatively seldom studied. Our previous studies showed that Dock2-/- mice were highly susceptible to colitis induced by Citrobacter rodentium infection, and in early infection, Dock2-/- mice had defects in macrophage migration. However, the specific roles of Dock2 in the migration and functions of macrophages are not clear. In this study, we found that the expression of chemokines such as chemokine (C-C motif) ligand (CCL)4 and CCL5 and chemokine receptors such as chemokine (C-C motif) receptor (CCR)4 and CCR5 in bone marrow-derived macrophages (BMDM) of Dock2-/- mice decreased after infection, which were supported by the in-vivo infection experimental results; the Transwell experiment results showed that Dock2-/- BMDM had a defect in chemotaxis. The bacterial phagocytic and bactericidal experiment results also showed that Dock2-/- BMDM had the defects of bacterial phagocytosis and killing. Furthermore, the adoptive transfer of wild-type BMDM alleviated the susceptibility of Dock2-/- mice to C. rodentium infection. Our results show that Dock2 affects migration and phagocytic and bactericidal ability of macrophages by regulating the expression of chemokines, chemokine receptors and their responses to chemokine stimulation, thus playing an essential role in the host defense against enteric bacterial infection.
© 2021 British Society for Immunology.

Entities:  

Keywords:  zzm321990Citrobacter rodentiumzzm321990; Dock2; chemokine; colitis; macrophage

Mesh:

Substances:

Year:  2021        PMID: 33662140      PMCID: PMC8119830          DOI: 10.1111/cei.13590

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  45 in total

1.  Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages.

Authors:  Paola Di Marzio; Wei Wei Dai; Giovanni Franchin; Amanda Y Chan; Marc Symons; Barbara Sherry
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

Review 2.  Immune regulatory functions of DOCK family proteins in health and disease.

Authors:  Akihiko Nishikimi; Mutsuko Kukimoto-Niino; Shigeyuki Yokoyama; Yoshinori Fukui
Journal:  Exp Cell Res       Date:  2013-08-02       Impact factor: 3.905

3.  Growth of B Cell Receptor Microclusters Is Regulated by PIP2 and PIP3 Equilibrium and Dock2 Recruitment and Activation.

Authors:  Jing Wang; Liling Xu; Samina Shaheen; Sichen Liu; Wenjie Zheng; Xiaolin Sun; Zhanguo Li; Wanli Liu
Journal:  Cell Rep       Date:  2017-11-28       Impact factor: 9.423

Review 4.  Citrobacter rodentium of mice and man.

Authors:  Rosanna Mundy; Thomas T MacDonald; Gordon Dougan; Gad Frankel; Siouxsie Wiles
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

Review 5.  Dock-family exchange factors in cell migration and disease.

Authors:  Gilles Gadea; Anne Blangy
Journal:  Eur J Cell Biol       Date:  2014-06-24       Impact factor: 4.492

6.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

7.  Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration.

Authors:  Cornelia Weiss-Haljiti; Christian Pasquali; Hong Ji; Corine Gillieron; Christian Chabert; Marie-Laure Curchod; Emilio Hirsch; Anne J Ridley; Rob Hooft van Huijsduijnen; Montserrat Camps; Christian Rommel
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

8.  Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.

Authors:  César Nombela-Arrieta; Rosa Ana Lacalle; María C Montoya; Yuya Kunisaki; Diego Megías; Miriam Marqués; Ana C Carrera; Santos Mañes; Yoshinori Fukui; Carlos Martínez-A; Jens V Stein
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

9.  MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation.

Authors:  Masatoshi Hori; Hiromi Nobe; Kazuhide Horiguchi; Hiroshi Ozaki
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-31       Impact factor: 4.249

10.  Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis.

Authors:  Akihiko Nishikimi; Hideo Fukuhara; Wenjuan Su; Tsunaki Hongu; Shunsuke Takasuga; Hisashi Mihara; Qinhong Cao; Fumiyuki Sanematsu; Motomu Kanai; Hiroshi Hasegawa; Yoshihiko Tanaka; Masakatsu Shibasaki; Yasunori Kanaho; Takehiko Sasaki; Michael A Frohman; Yoshinori Fukui
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

View more
  3 in total

1.  DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.

Authors:  Xia Guo; Oluwaseun Adeyanju; Christudas Sunil; Venkatakirankumar Mandlem; Ayobami Olajuyin; Steven Huang; Shi-You Chen; Steven Idell; Torry A Tucker; Guoqing Qian
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-18       Impact factor: 5.282

2.  The role of microglial/macrophagic salt-inducible kinase 3 on normal and excessive phagocytosis after transient focal cerebral ischemia.

Authors:  Ke Wang; Chenran Wang; Di Chen; Yichen Huang; Jiaying Li; Pengju Wei; Ziyu Shi; Yue Zhang; Yanqin Gao
Journal:  Cell Mol Life Sci       Date:  2022-07-21       Impact factor: 9.207

Review 3.  Insights from DOCK2 in cell function and pathophysiology.

Authors:  Lulin Ji; Shuquan Xu; Haiqing Luo; Fanwei Zeng
Journal:  Front Mol Biosci       Date:  2022-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.